Arbutus Biopharma Corp (ABUS) Operating income 2016–2025
Arbutus Biopharma Corp (ABUS) annual operating income history from SEC filings — each fiscal year as reported.
-$38.2MFY2025 · since FY2016: -$491.6M → -$38.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$38.2M | +50.0% |
| FY2024 | -$76.3M | +2.3% |
| FY2023 | -$78.1M | -19.3% |
| FY2022 | -$65.5M | +11.0% |
| FY2021 | -$73.5M | -27.2% |
| FY2020 | -$57.8M | +59.8% |
| FY2019 | -$143.9M | -60.3% |
| FY2018 | -$89.8M | +19.1% |
| FY2017 | -$110.9M | +77.4% |
| FY2016 | -$491.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice